Risk of serious infections in patients with rheumatoid arthritis treated in routine care with abatacept, rituximab and tocilizumab in Denmark and Sweden

Kathrine Lederballe Grøn*, Elizabeth V. Arkema, Bente Glintborg, Frank Mehnert, Mikkel Østergaard, Lene Dreyer, Mette Nørgaard, Niels Steen Krogh, Johan Askling, Merete Lund Hetland

*Corresponding author for this work
18 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Risk of serious infections in patients with rheumatoid arthritis treated in routine care with abatacept, rituximab and tocilizumab in Denmark and Sweden'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology

Biochemistry, Genetics and Molecular Biology